The Harm of E-cigarettes is Lower than FDA-approved Nicotine Therapies

Jul.01.2022

The Harm of E-cigarettes is Lower than FDA-approved Nicotine Therapies

E-cigarettes are safer and more effective than FDA-approved nicotine gum and patches, according to an article by Guy Bentley.

Guy Bentley, the Consumer Freedom Director at the American Institute for Economic Research, stated on the institute's website that e-cigarettes not only have lower risks than combustible cigarettes, but are also more effective than FDA-approved nicotine gum and patches.

He believes that the US Food and Drug Administration acknowledged this when it authorized Vuse e-cigarettes in 2021, stating that it recognizes the role of such safer nicotine alternatives in reducing smoking. If the Juul ban is implemented, many Juul users may resort to smoking again, while some smokers who were meant to transition to Juul may continue using traditional cigarettes.

Bentley criticized the FDA for going against its own claim to be acting in the best interest of public health by rejecting Juul's application. A study published in the New England Journal of Medicine found that e-cigarettes are twice as effective as traditional nicotine replacement therapy. This decision also exposes a logical inconsistency in the FDA's recently announced policy to lower nicotine levels in cigarettes to non-addictive levels, as smokers may simply smoke more to compensate for the lower nicotine content.

Bentley stated, "The agency's promise to transition smokers to safer alternatives rings hollow by banning the most popular e-cigarettes among adults.

This article is a compilation of information from third-party sources. Copyright for the compiled information belongs to the original media outlets and authors.

#Traditional tobacco #Legislation #Africa #Zimbabwe #FDA #E-cigarette #E-cigarettes and Tobacco #Nicotine e-cigarettes #Nicotine-containing e-cigarettes

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

EVO NXT European Tobacco & NGP Exhibition

EVO NXT European Tobacco & NGP Exhibition

Special Report｜Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?

Special Report｜Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?

Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.

Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race

Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race

Nicokick.com said it will continue its collaboration with zone for a second year at the April 19 NASCAR race in Kansas City, appearing on Richard Childress Racing’s No. 8 Chevrolet driven by Kyle Busch. The 2026 race-weekend campaign for verified adult nicotine consumers aged 21 and older includes the exclusive launch of zone Cranberry and a limited-edition five-flavor mix pack selected by Busch.

Apr.16 by 2FIRSTS.ai

ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson

ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson

Philip Morris Japan announced on April 23 at a product briefing that ZYN by IQOS, an oral tobacco pouch previously launched in selected areas, will expand sales in Tokyo. The company said the product will be released progressively from May 11 through IQOS shops, Lawson and other outlets in the city. The launch will include four flavors, each offered in Low and Medium intensity levels, for a total of eight products.

Apr.27 by 2FIRSTS.ai

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on Tuesday in a case brought by seven small vape-liquid companies challenging the Food and Drug Administration’s denial of marketing authorization for their flavored electronic nicotine products.

Apr.30 by 2FIRSTS.ai

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation

U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.

PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation

PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation

PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.

Apr.15 by 2FIRSTS.ai

Related Topics

News

Related Read

Special Report｜Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?

Special Report｜Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?

Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race

Nicokick and zone Extend NASCAR Collaboration for April 19 Kansas City Race

ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson

ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation

CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation

PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation

PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation